Covered recipient · General Payments record
JASON ROCK STANDRING
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,650.13
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $340.22 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $136.76 | 11 |
| Mylan Specialty L.P. | $64.65 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $35.38 | 2 |
| MIMEDX Group, Inc. | $22.12 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.62 | 1 |
| Lilly USA, LLC | $17.37 | 1 |
| Innovation Technologies Inc | $15.56 | 1 |
| Endo USA, Inc. | $15.07 | 1 |
| Merck Sharp & Dohme Corporation | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.67 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153375 | CMS |
| ABBVIE INC. | $1.69 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153377 | CMS |
| ABBVIE INC. | $3.15 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153379 | CMS |
| ABBVIE INC. | $17.43 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153381 | CMS |
| ABBVIE INC. | $19.30 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153383 | CMS |
| ABBVIE INC. | $23.24 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153385 | CMS |
| ABBVIE INC. | $3.49 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153387 | CMS |
| ABBVIE INC. | $26.76 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153389 | CMS |
| ABBVIE INC. | $20.58 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153391 | CMS |
| ABBVIE INC. | $3.24 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153393 | CMS |
| ABBVIE INC. | $15.21 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153395 | CMS |
| Boston Scientific Corporation | $20.31 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092664873 | CMS |
| Boston Scientific Corporation | $15.07 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092664871 | CMS |
| Endo USA, Inc. | $15.07 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138588306 | CMS |
| Innovation Technologies Inc | $15.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130824167 | CMS |
| Lilly USA, LLC | $17.37 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031828 | CMS |
| Merck Sharp & Dohme LLC | $14.69 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141961062 | CMS |
| MIMEDX Group, Inc. | $22.12 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270000 | CMS |
| Mylan Specialty L.P. | $22.02 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147352293 | CMS |
| Mylan Specialty L.P. | $18.96 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147341162 | CMS |
| Mylan Specialty L.P. | $23.67 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147369647 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.62 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598052 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.